Compare LTRN & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTRN | NMTC |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 8.1M |
| IPO Year | 2020 | 2010 |
| Metric | LTRN | NMTC |
|---|---|---|
| Price | $0.29 | $0.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $17.50 | $7.27 |
| AVG Volume (30 Days) | ★ 166.9K | 45.6K |
| Earning Date | 11-17-2026 | 12-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.65 | ★ 80.43 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $9,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $25.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $0.36 | $0.61 |
| 52 Week High | $4.34 | $12.24 |
| Indicator | LTRN | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 20.94 | 32.81 |
| Support Level | N/A | $0.61 |
| Resistance Level | $0.84 | $1.35 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 0.07 | 6.94 |
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.